Snake-oil, quack medicine, and industrially cultured organisms: Biovalue and the commercialization of human microbiome research

BMC Medical Ethics

Volumn 13, Issue 1, 2012, Pages

  Slashinski, Melody J ^a   McCurdy, Sheryl A ^b   Achenbaum, Laura S ^a   Whitney, Simon N ^a   McGuire, Amy L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Commercialization; Dietary supplements; Ethical legal and social implications (ELSI); Human microbiome; Qualitative research

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; AWARENESS; COMMERCIAL PHENOMENA; DIET SUPPLEMENTATION; DRUG INDUSTRY; ETHICS; HUMAN; METAGENOME; PUBLIC HEALTH; PUBLIC OPINION; QUACKERY; RESEARCH; RESEARCH ETHICS; TECHNOLOGY;

AWARENESS; COMMERCE; DIETARY SUPPLEMENTS; DRUG INDUSTRY; ETHICS, RESEARCH; HUMANS; METAGENOME; PROBIOTICS; PUBLIC HEALTH; PUBLIC OPINION; QUACKERY; RESEARCH; TECHNOLOGY TRANSFER;

EID: 84867895760     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/1472-6939-13-28     Document Type: Article

References (34)

1. Ethical, legal, and social considerations in conducting the human microbiome project. McGuire AL, Colgrove J, Whitney SN, Diaz CM, Bustillos D, Versalovic J, Genome Res 2008 18 1861 1864 10.1101/gr.081653.108 18971311
2. Dietary supplement use in the United States, 2003-2006. Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, Betz JM, Sempos CT, Picciano MF, J Nutr 2011 141 261 266 10.3945/jn.110.133025 21178089
3. Institute of Medicine of the National Academies, Dietary supplements: a framework for evaluating safety 2004 Accessed November 10, 2011 at http://www.iom.edu/Reports/2004/Dietary-Supplements-A-Framework-for-Evaluating- Safety.aspx
4. The science and regulation of probiotic food and supplement product labeling. Sanders ME, Levy DD, Ann NY Acad Sci 2011 1219 Suppl 1 1 E23 21332758
5. Position of the American dietetic association: functional foods. American Dietetic Association, J Am Diet Assoc 2009 109 735 746 19338113
6. How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome. Mercer MB, Brinich MA, Gellar G, Harrison K, Highland J, James K, Marshall P, McCormick JB, Tilburt J, Achkar JP, Farrell RM, Sharp RR, J Clin Gastroenterol 2012 46 138 144 10.1097/MCG.0b013e318225f545 21716123
7. Helping patients make informed choices about probiotics: a need for research. Sharp RR, Achkar JP, Brinich MA, Farrell RM, Am J Gastroenterol 2009 104 809 813 10.1038/ajg.2008.68 19343022
8. Waldby C, The visible human project: informatic bodies and posthuman medicine Routledge, New York 2000
9. National Institutes of Health Common Fund, Human microbiome project overview Accessed February 1, 2012 at http://commonfund.nih.gov/Hmp/overview. aspx
10. The human microbiome project: a strategy to understand the microbial components of the human genetic and metabolic landscape and how they contribute to normal physiology and predisposition to disease. Turnabugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI, Nature 2007 449 804 810 10.1038/nature06244 17943116 (Pubitemid 47598620)
11. The human microbiome project, personalized medicine and the birth of pharmacomicrobiomics. Rizkallah MR, Saad R, Aziz RK, Curr Pharmacogenomics Person Med 2010 8 182 193
12. A core gut microbiome in obese and lean twins. Turnbaugh PJ, Hamady M, Yatsuneko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI, Nature 2008 457 480 484 19043404
13. The human microbiome project in 2011 and beyond. Proctor L, Cell Host Microbe 2011 10 287 291 10.1016/j.chom.2011.10.001 22018227
14. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Koren O, Spor A, Felin J, Fåk F, Stombaugh J, Tremaroli V, Behre CJ, Knight R, Fagerberg B, Ley RE, Bäckhed F, PNAS 2011 108 4592 4598 10.1073/pnas.1011383107 20937873
15. Studying the enteric microbiome in inflammatory bowel diseases: getting through the growing pains and moving forward. Young VB, Kahn SA, Schmidt TM, Chang EB, Front Microbio 2011 2 [ http://www.frontiersin.org/Cellular-and- Infection-Microbiology-closed-section/10.3389/fmicb.2011.00144/full ]
16. Development of a fluorophore-ribosomal DNA restriction typing method for monitoring structural microbial communities. Wang T, Zhang X, Zhang M, Wang L, Zhao L, Arch Microbiol 2011 193 341 350 21274516
17. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A, Gastroenterology 2007 133 24 33 10.1053/j.gastro.2007.04.005 17631127 (Pubitemid 47031125)
18. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA, Gastroenterology 2011 140 976 986 10.1053/j.gastro.2010.11.049 21129376
19. Microbiome aspects of perinatal and neonatal health. Gregory KE, J Perinat Neonatal Nurs 2011 25 158 162 21540692
20. A novel abundance-based algorithm for binning metagenomic sequences using -tuples. Wu Y, Ye Y, J Comput Biol 2011 18 523 534 10.1089/cmb.2010.0245 21385052
21. FR-HIT, a very fast program to recruit metagenomic reads to homologous reference genomes. Niu B, Zhu Z, Fu L, Wu S, Li W, Bioinformatics 2011 27 1704 1705 10.1093/bioinformatics/btr252 21505035
22. ALignment editor (ALE) a web-based RNA alignment tool. Stombaugh J, Widmann J, McDonald D, Knight R, Boulder, Bioinformatics 2011 27 1706 1707 10.1093/bioinformatics/btr258 21546392
23. Creswell JW, Qualitative inquiry and research design: choosing among five approaches Sage, Thousand Oaks 2007
24. Guest G, MacQueen KM, Handbook for team-based qualitative research AltaMira Press, Lanham 2008
25. Perspectives on human microbiome research ethics. McGuire AL, Achenbaum LS, Whitney SN, Slashinski MJ, Versalovic J, Keitel WA, McCurdy S, J Empirical Res Human Res Ethics 2012 7 1 14
26. Bacterial community variation in human body habitats across space and time. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R, Science 2009 326 1694 1697 10.1126/science.1177486 19892944
27. Tannock GW, Probiotics: a critical review Horizon Scientific Press, Wymondham 1999
28. Probiotics: facts and myths. Senok AC, Ismaeel AY, Botta GA, Clin Microbiol Infect 2005 11 958 966 10.1111/j.1469-0691.2005.01228.x 16307549 (Pubitemid 41748929)
29. Nettleton S, The sociology of health and illness Polity, Malden 2006
30. Dietary supplement health and education Act Pub L. No. 103-417 (October 25, 1994)
31. From evidence-based medicine to marketing-based medicine: evidence from internal industry documents. Spielmans GI, Parry PI, J Bioeth Inq 2010 7 13 29 10.1007/s11673-010-9208-8
32. Little bottles and the promise of probiotics. Watson DB, Moreira T, Murtagh M, Health (London) 2009 13 219 234 10.1177/1363459308099685
33. Federal Trade Commission, Enforcement policy statement on food advertising 1994 Accessed November 10, 2011 at http://www.ftc.gov/bcp/ policystmt/ad-food.shtm
34. Who owns your poop?: insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies. Hawkins AK, ODoherty C, BMC Med Genomics 2011 4 72 [ http://www.biomedcentral. com/1755-8794/4/72 ] 10.1186/1755-8794-4-72 21982589